# Unicycive Therapeutics, Inc.: Form 8-K, filed Aug 18, 2025

- Company: [Unicycive Therapeutics, Inc.](/companies/uncy.md) (CIK 1766140)
- Form: 8-K
- Filed: 2025-08-18
- Accepted by EDGAR: Aug 18, 2025, 16:17 ET
- Period: 2025-08-15
- Accession: 0001213900-25-077937
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1766140/000121390025077937/ea0253753-8k_unicycive.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1766140/000121390025077937/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1766140/000121390025077937/ea0253753-8k_unicycive.htm

Filed Aug 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-077937. Last ingested by Listed: Oct 29, 2026, 16:30 ET. No prices; not investment advice.